Rice Hall James & Associates’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4M Sell
53,588
-495
-0.9% -$36.9K 0.22% 97
2025
Q1
$3.44M Buy
54,083
+7,740
+17% +$492K 0.2% 111
2024
Q4
$3.62M Sell
46,343
-384
-0.8% -$30K 0.2% 121
2024
Q3
$3.76M Sell
46,727
-604
-1% -$48.6K 0.2% 113
2024
Q2
$3.92M Sell
47,331
-533
-1% -$44.1K 0.23% 94
2024
Q1
$4.09M Sell
47,864
-9,157
-16% -$782K 0.23% 91
2023
Q4
$4.88M Sell
57,021
-812
-1% -$69.4K 0.28% 84
2023
Q3
$5.18M Buy
57,833
+6,972
+14% +$625K 0.33% 75
2023
Q2
$4.33M Sell
50,861
-7,853
-13% -$669K 0.25% 98
2023
Q1
$4.86M Buy
58,714
+6,088
+12% +$504K 0.28% 88
2022
Q4
$4.14M Sell
52,626
-29,997
-36% -$2.36M 0.24% 97
2022
Q3
$6.12M Buy
82,623
+5,297
+7% +$392K 0.35% 67
2022
Q2
$5.04M Buy
77,326
+681
+0.9% +$44.4K 0.24% 83
2022
Q1
$4.85M Buy
76,645
+18,766
+32% +$1.19M 0.19% 101
2021
Q4
$3.07M Buy
57,879
+14,647
+34% +$777K 0.11% 173
2021
Q3
$3.05M Buy
+43,232
New +$3.05M 0.11% 144
2017
Q2
Sell
-117,978
Closed -$4.79M 297
2017
Q1
$4.79M Sell
117,978
-12,290
-9% -$499K 0.23% 101
2016
Q4
$5.24M Sell
130,268
-303
-0.2% -$12.2K 0.26% 95
2016
Q3
$4.73M Buy
130,571
+14,450
+12% +$523K 0.25% 98
2016
Q2
$3.37M Buy
116,121
+1,645
+1% +$47.7K 0.19% 98
2016
Q1
$4M Buy
114,476
+3,196
+3% +$112K 0.23% 97
2015
Q4
$3.59M Buy
111,280
+48,303
+77% +$1.56M 0.21% 108
2015
Q3
$2.04M Buy
+62,977
New +$2.04M 0.13% 166
2014
Q1
Sell
-302,993
Closed -$12.8M 307
2013
Q4
$12.8M Buy
302,993
+67,873
+29% +$2.86M 0.92% 44
2013
Q3
$9.38M Sell
235,120
-22,663
-9% -$904K 0.9% 44
2013
Q2
$10.7M Buy
+257,783
New +$10.7M 1.05% 35